The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Open accessAbstract
We investigated whether withanolide A (WL-A), isolated from the Indian herbal drug Ashwagandha (root of Withania somnifera), could regenerate neurites and reconstruct synapses in severely damaged neurons. We also investigated the effect of WL-A on memory-deficient mice showing neuronal atrophy and synaptic loss in the brain. Axons, dendrites, presynapses, and postsynapses were visualized by immunostaining for phosphorylated neurofilament-H (NF-H), microtubule-associated protein 2 (MAP2), synaptophysin, and postsynaptic density-95 (PSD-95), respectively. Treatment with A beta(25-35) (10 microM) induced axonal and dendritic atrophy, and pre- and postsynaptic loss in cultured rat cortical neurons. Subsequent treatment with WL-A (1 microM) induced significant regeneration of both axons and dendrites, in addition to the reconstruction of pre- and postsynapses in the neurons. WL-A (10 micromol kg(-1) day(-1), for 13 days, p.o.) recovered A beta(25-35)-induced memory deficit in mice. At that time, the decline of axons, dendrites, and synapses in the cerebral cortex and hippocampus was almost recovered. WL-A is therefore an important candidate for the therapeutic treatment of neurodegenerative diseases, as it is able to reconstruct neuronal networks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the ameliorative outcomes were retained after treatment discontinuation [89].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted:Nootropic‐like effect of ashwagandha (Withania somnifera L.) in mice
Dhuley, J. N. (2001) · Phytotherapy Research · doi:10.1002/ptr.874 · Cited by 85
RetractedTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurotrophins regulate dendritic growth in developing visual cortex
McAllister, A. K., Lo, D. C., & Katz, L. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90171-x · Cited by 959
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530
Assembly of New Individual Excitatory Synapses
Friedman, H., Bresler, T., Garner, C. C., & Ziv, N. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)00009-x · Cited by 499
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I. M., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371
Dickson, T. C., & Vickers, J. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00169-5 · Cited by 294
Spine Formation and Correlated Assembly of Presynaptic and Postsynaptic Molecules
Okabe, S., Miwa, A., & Okado, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06105.2001 · Cited by 291
Stages of Synapse Development Defined by Dependence on F-Actin
Zhang, W., & Benson, D. L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05169.2001 · Cited by 262
Neurotrophins promote maturation of developing neuromuscular synapses
Wang, T., Xie, K., & Lu, B. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04796.1995 · Cited by 251
Knowles, R. B., Wyart, C., Buldyrev, S. V., Cruz, L., Urbanc, B., Hasselmo, M. E., Stanley, H. E., & Hyman, B. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5274 · Cited by 241
BOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., MILLER, D. C., & WISNIEWSKI, H. M. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00010 · Cited by 208 · cited 1×
“…Group All rights reserved 0007–1188/05 $30.00 www.nature.com/bjp et al., 1994); amyloid b forms deposits in the brain, and subsequently induces neuronal cell death (Bobinski et al., 1997), neuritic atrophy (Canning et al., 1993; Knowles et al., 1999), and synaptic loss (Terry et al., 1991).”
BackgroundInfluentialAkama, K. T., & McEwen, B. S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02333.2003 · Cited by 198
Withanolide Derivatives from the Roots of Withania somnifera and Their Neurite Outgrowth Activities.
Zhao, J., Nakamura, N., Hattori, M., Kuboyama, T., Tohda, C., & Komatsu, K. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.760 · Cited by 194
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 192
Grace, E. A., Rabiner, C. A., & Busciglio, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00241-5 · Cited by 153
β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth
Canning, D. R., McKeon, R. J., DeWitt, D. A., Perry, G. L., Wujek, J. R., Frederickson, R. C. A., & Silver, J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1199 · Cited by 147
Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha
Kuboyama, T., Tohda, C., Zhao, J., Nakamura, N., Hattori, M., & Komatsu, K. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00005 · Cited by 146
Tohda, C., Matsumoto, N., Zou, K., Meselhy, M. R., & Komatsu, K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300388 · Cited by 142
Cholesterol‐dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons
Fan, Q., Yu, W., Gong, J., Zou, K., Sawamura, N., Senda, T., Yanagisawa, K., & Michikawa, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00686.x · Cited by 134
Neurotrophic and Neuroprotective Actions of Ginsenosides Rb1 and Rg1
Rudakewich, M., Ba, F., & Benishin, C. G. (2001) · Planta Medica · doi:10.1055/s-2001-16488 · Cited by 124
Hiruma, H., Katakura, T., Takahashi, S., Ichikawa, T., & Kawakami, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08967.2003 · Cited by 114
Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113
Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells
Tohda, C., Kuboyama, T., & Komatsu, K. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00035 · Cited by 109
Yokomaku, D., Numakawa, T., Numakawa, Y., Suzuki, S., Matsumoto, T., Adachi, N., Nishio, C., Taguchi, T., & Hatanaka, H. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0314 · Cited by 108
Mattila, P., Rinne, J., Helenius, H., & Röyttä, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010051064 · Cited by 95
The cortical neuritic pathology of Huntington's disease
Jackson, M., Gentleman, S. M., Lennox, G. G., Ward, L., Gray, T. B., Randall, K., Morrell, K., & Lowe, J. S. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01024.x · Cited by 89
Yamazaki, M., Chiba, K., Mohri, T., & Hatanaka, H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00533.x · Cited by 72
Dominguez, R., Jalali, C., & Lacalle, S. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2586-03.2004 · Cited by 61
Postuma, R. B., He, W., Nunan, J., Beyreuther, K. T., Masters, C. L., Barrow, C. J., & Small, D. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741122.x · Cited by 56
Tohda, C., Tamura, T., & Komatsu, K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03449-8 · Cited by 56
Neuroaxonal pathology in Creutzfeldt-Jakob disease
Liberski, P. P., & Budka, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010050995 · Cited by 53
Alzheimer pathology of patients carrying apoliprotein E ε4 allele
Heinonen, O. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00076-q · Cited by 52
Coffey, E. T., Åkerman, K. E. O., & Courtney, M. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00335-2 · Cited by 48
Nardosinone, a novel enhancer of nerve growth factor in neurite outgrowth from PC12D cells
Li, P., Matsunaga, K., Yamamoto, K., Yoshikawa, R., Kawashima, K., & Ohizumi, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00629-1 · Cited by 47
Audesirk, T., Cabell, L., Kern, M., & Audesirk, G. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00294-x · Cited by 39
Studer, L., Spenger, C., Luthman, J., & Seiler, R. W. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903400212 · Cited by 37
Cambiasso, M. J., & Carrer, H. F. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1238 · Cited by 34
Two types of aggregate in the cerebral cortex of a seizure-sensitive strain of the Mongolian gerbil
Seto‐Ohshima, A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00873-3 · Cited by 3
PLAQUE-INDUCED NEURITE ABNORMALITIES
Hyman, B. T., Knowles, R. B., Wyart, C., Buldyrev, S. V., Cruz, L., Urbanc, B., Hasselmo, M. E., & Stanley, E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199905000-00204 · Cited by 1
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Withania somnifera: an Indian ginseng
Kulkarni, S. K., & Dhir, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.011 · Cited by 416
Sehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., Khanna, P., Jain, S. C., Thakur, S. S., & Ravindranath, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112209109 · Cited by 390
Natural withanolides: an overview
Chen, L.-X., He, H., & Qiu, F. (2011) · Natural Product Reports · doi:10.1039/c0np00045k · Cited by 360
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Search for natural products related to regeneration of the neuronal network
Tohda, C., Kuboyama, T., & Komatsu, K. (2005) · Neurosignals · doi:10.1159/000085384 · Cited by 257
Metadata
- Authors
- Kuboyama, T., Tohda, C., & Komatsu, K.
- Affiliations
- University of Toyama (JP)
- Institute of Natural Medicine, University of Toyama (JP)
- Corresponding author
- Komatsu, Katsuko
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 144
- Issue
- 7
- Pages
- 961-971
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1576076
- OpenAlex
- W2062620653
- Cited by
- 339
- References
- 45
- Citations by year
- 2026: 17 · 2025: 12 · 2024: 21 · 2023: 25 · 2022: 20 · 2021: 21 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 22 · 2016: 20 · 2015: 23 · 2014: 16 · 2013: 21 · 2012: 15
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- withanolide A, Withania somnifera, neurite regeneration, axonal atrophy, dendritic atrophy, synaptic loss, amyloid beta 25-35, memory impairment, neurodegenerative diseases, neurofilament H, synaptophysin, PSD-95, cortical neurons, hippocampus, neuroprotection
- MeSH terms
- Animals, Cells, Cultured, Female, Nerve Regeneration, Plant Extracts, Pregnancy, Synapses, Neurites, Rats, Sprague-Dawley, Plant Roots, Withania, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
